Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
| ▸ | HTR2C | P28335 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8969263 | 0.89 | CTSD (0.33) | HTR2AHTR2CHTR2BNOS3NOS1 | |
| SCHEMBL8969504 | 0.83 | ACHE (0.40) | PDE3BPDE3AHTR2AHTR2CHTR2B | |
| SCHEMBL8969419 | 0.83 | — | — | |
| SCHEMBL8969737 | 0.83 | OPRM1 (0.31) | — | |
| SCHEMBL8968791 | 0.82 | HTR2A (0.34) | PDE3BPDE3AHTR2AHTR2CHTR2B | |
| SCHEMBL8968239 | 0.78 | — | — | |
| SCHEMBL8969463 | 0.78 | HTR2A (0.33) | HTR2AHTR2CHTR2B | |
| SCHEMBL8970140 | 0.77 | CTSD (0.32) | — | |
| SCHEMBL8969633 | 0.77 | CTSD (0.41) | HTR2C | |
| SCHEMBL8968760 | 0.75 | PDE3B (0.34) | PDE3BPDE3AHTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5486512-A | LEARNING ENHANCEMENT | WARNER-LAMBERT COMPANY (US) | 1996-01-23 | — | — | US | disclosed |
| WO-1993003034-A1 | QUINAZOLINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 1993-02-18 | — | — | WO | disclosed |